ANEW Medical Other Long-Term Assets 2023-2024 | KLTO

ANEW Medical other long-term assets from 2023 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
ANEW Medical Annual Other Long-Term Assets
(Millions of US $)
ANEW Medical Quarterly Other Long-Term Assets
(Millions of US $)
2024-06-30
2022-03-31
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.015B $0.000B
ANEW MEDICAL INC. specializes in the development of diagnostics and novel disease-modifying therapies for neurological and age-related disorders. The company's focus on central nervous systems diseases utilizing cell and gene therapies to mitigate age-related pathologies such as Alzheimer's disease, dementia symptoms and neuromuscular diseases. ANEW MEDICAL INC., formerly known as REDWOODS ACQ, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Plum Acquisition I (VEEA) United States $0.138B 0.00
Pono Capital Two (SBC) United States $0.000B 0.00
Edgio (EGIOQ) United States $0.000B 0.00